These final results, together with a previous report demonstrating that a small-molecule ACKR3 agonist CCX771 displays anxiolytic-like actions in mice,2 support the strategy of targeting ACKR3 as a singular method to modulate the opioid program, which could open up new therapeutic avenues for opioid-related disorders. (2) The doctor has https://williamx066zny1.slypage.com/profile